Literature DB >> 30087120

Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Huabo Wang1, James M Dolezal1, Sucheta Kulkarni1, Jie Lu1, Jordan Mandel1, Laura E Jackson1, Frances Alencastro2, Andrew W Duncan2,3, Edward V Prochownik4,3,5,6.   

Abstract

Analogous to the c-Myc (Myc)/Max family of bHLH-ZIP transcription factors, there exists a parallel regulatory network of structurally and functionally related proteins with Myc-like functions. Two related Myc-like paralogs, termed MondoA and MondoB/carbohydrate response element-binding protein (ChREBP), up-regulate gene expression in heterodimeric association with the bHLH-ZIP Max-like factor Mlx. Myc is necessary to support liver cancer growth, but not for normal hepatocyte proliferation. Here, we investigated ChREBP's role in these processes and its relationship to Myc. Unlike Myc loss, ChREBP loss conferred a proliferative disadvantage to normal murine hepatocytes, as did the combined loss of ChREBP and Myc. Moreover, hepatoblastomas (HBs) originating in myc-/-, chrebp-/-, or myc-/-/chrebp-/- backgrounds grew significantly more slowly. Metabolic studies on livers and HBs in all three genetic backgrounds revealed marked differences in oxidative phosphorylation, fatty acid β-oxidation (FAO), and pyruvate dehydrogenase activity. RNA-Seq of livers and HBs suggested seven distinct mechanisms of Myc-ChREBP target gene regulation. Gene ontology analysis indicated that many transcripts deregulated in the chrebp-/- background encode enzymes functioning in glycolysis, the TCA cycle, and β- and ω-FAO, whereas those dysregulated in the myc-/- background encode enzymes functioning in glycolysis, glutaminolysis, and sterol biosynthesis. In the myc-/-/chrebp-/- background, additional deregulated transcripts included those involved in peroxisomal β- and α-FAO. Finally, we observed that Myc and ChREBP cooperatively up-regulated virtually all ribosomal protein genes. Our findings define the individual and cooperative proliferative, metabolic, and transcriptional roles for the "Extended Myc Network" under both normal and neoplastic conditions.
© 2018 Wang et al.

Entities:  

Keywords:  MYC proto-oncogene bHLH transcription factor; MondoA; Myc (c-Myc); Oxphos; Warburg effect; fatty acid oxidation; hepatoblastoma; hepatocellular carcinoma; liver cancer; mitochondria

Mesh:

Substances:

Year:  2018        PMID: 30087120      PMCID: PMC6153302          DOI: 10.1074/jbc.RA118.004099

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.

Authors:  Huabo Wang; Jie Lu; Lia R Edmunds; Sucheta Kulkarni; James Dolezal; Junyan Tao; Sarangarajan Ranganathan; Laura Jackson; Marc Fromherz; Donna Beer-Stolz; Radha Uppala; Sivakama Bharathi; Satdarshan P Monga; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

2.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 3.  Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks.

Authors:  John M O'Shea; Donald E Ayer
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 4.  Cancer metabolism: key players in metabolic reprogramming.

Authors:  Tomoyoshi Soga
Journal:  Cancer Sci       Date:  2013-01-31       Impact factor: 6.716

Review 5.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 6.  The role of pluripotency factors to drive stemness in gastrointestinal cancer.

Authors:  Martin Müller; Patrick C Hermann; Stefan Liebau; Clair Weidgang; Thomas Seufferlein; Alexander Kleger; Lukas Perkhofer
Journal:  Stem Cell Res       Date:  2016-02-03       Impact factor: 2.020

7.  Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family.

Authors:  M Landay; S K Oster; F Khosravi; L E Grove; X Yin; J Sedivy; L Z Penn; E V Prochownik
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

8.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

Review 9.  Tyrosinaemia--treatment and outcome.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 10.  Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.

Authors:  Agnieszka Loboda; Milena Damulewicz; Elzbieta Pyza; Alicja Jozkowicz; Jozef Dulak
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

View more
  10 in total

1.  A lack of ChREBP inhibits mitochondrial cristae formation in brown adipose tissue.

Authors:  Haruhiko Sakiyama; Lan Li; Sachi Kuwahara-Otani; Tsutomu Nakagawa; Hironobu Eguchi; Daisaku Yoshihara; Masakazu Shinohara; Noriko Fujiwara; Keiichiro Suzuki
Journal:  Mol Cell Biochem       Date:  2021-05-21       Impact factor: 3.396

2.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

Review 3.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

4.  The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Pei Feng Cheng; Sivakanthan Kasinathan; Haiwei Gu; Theresa Hedrich; James A Dowdle; Vivek Venkataramani; Vijay Ramani; Xiaoying Wu; Daniel Raftery; Jay Shendure; Donald E Ayer; Charles H Muller; Robert N Eisenman
Journal:  PLoS Biol       Date:  2021-10-20       Impact factor: 9.593

Review 5.  Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.

Authors:  Edward V Prochownik
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

6.  RNA-Seq transcriptome profiling in three liver regeneration models in rats: comparative analysis of partial hepatectomy, ALLPS, and PVL.

Authors:  Dilek Colak; Olfat Al-Harazi; Osama M Mustafa; Fanwei Meng; Abdullah M Assiri; Dipok K Dhar; Dieter C Broering
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

7.  Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia.

Authors:  Huabo Wang; Jie Lu; Frances Alencastro; Alexander Roberts; Julia Fiedor; Patrick Carroll; Robert N Eisenman; Sarangarajan Ranganathan; Michael Torbenson; Andrew W Duncan; Edward V Prochownik
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-03-05

Review 8.  The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

9.  Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation.

Authors:  Yu Lei; Shuling Zhou; Qiaoling Hu; Xueling Chen; Jiang Gu
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

Review 10.  Animal Modeling of Pediatric Liver Cancer.

Authors:  Richard S Whitlock; Tianyou Yang; Sanjeev A Vasudevan; Sarah E Woodfield
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.